Efficacy of Pentoxifylline as an Antifibrotic Drug in Experimental Murine Schistosomal Hepatic Fibrosis

Pentoxifylline and/or praziquantel reduce murine schistosomiasis mansoni histopathology via amelioration of liver functions

THE ANTIFIBROTIC POTENTIAL OF RESVERATROL IN SCHISTOSOMA MANSONI -INFECTED MICE

CLINICOPATHOLOGICAL STUDIES ON HEPATOPROTECTIVE EFFECT OF PENTOXIFYLLINE ON CCL4 INDUCED LIVER FIBROSIS IN GUINEA PIGS

Regulation of Liver Fibrosis during Murine Schistosomiasis Mansoni

ANTI-SCHISTOSOMAL AND ANTIFIBROTIC EFFECTS OF RESVERATROL LOADED ON NIOSOMES IN MURINE SCHISTOSOMIASIS MANSONI

Assessment of Antibilharzial and Biochemical Effects of Triclabendazol in Experimental Schistomiasis

Effect of Androgen and Schistosomicide In Murine Schistomiasis Mansoni: An Experimental Study

Angiotensin-Converting Enzyme Inhibitor “Lisinopril” Antagonizes Hepatic TGF-β1, improving Hepatic Fibrosis Caused by Experimental Schistosomiasis mansoni

Interferon-Α Immunotherapy, Combined with Praziquantel Downregulates VEGF Gene Expression, Causing Regression of Hepatic Fibrosis in Chronic Schistosoma Mansoni Experimental Infec